These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519 [TBL] [Abstract][Full Text] [Related]
26. Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner. Kato I; Maita H; Takahashi-Niki K; Saito Y; Noguchi N; Iguchi-Ariga SM; Ariga H Mol Cell Biol; 2013 Jan; 33(2):340-59. PubMed ID: 23149933 [TBL] [Abstract][Full Text] [Related]
27. DJ-1 has a role in antioxidative stress to prevent cell death. Taira T; Saito Y; Niki T; Iguchi-Ariga SM; Takahashi K; Ariga H EMBO Rep; 2004 Feb; 5(2):213-8. PubMed ID: 14749723 [TBL] [Abstract][Full Text] [Related]
28. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Waragai M; Wei J; Fujita M; Nakai M; Ho GJ; Masliah E; Akatsu H; Yamada T; Hashimoto M Biochem Biophys Res Commun; 2006 Jul; 345(3):967-72. PubMed ID: 16707095 [TBL] [Abstract][Full Text] [Related]
29. DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection. Wang Z; Liu J; Chen S; Wang Y; Cao L; Zhang Y; Kang W; Li H; Gui Y; Chen S; Ding J Ann Neurol; 2011 Oct; 70(4):591-9. PubMed ID: 21796667 [TBL] [Abstract][Full Text] [Related]
30. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661 [TBL] [Abstract][Full Text] [Related]
31. α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease. Waragai M; Sekiyama K; Sekigawa A; Takamatsu Y; Fujita M; Hashimoto M Int J Mol Sci; 2010 Oct; 11(11):4257-66. PubMed ID: 21151436 [TBL] [Abstract][Full Text] [Related]
32. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents. Galter D; Westerlund M; Belin AC; Olson L Physiol Behav; 2007 Sep; 92(1-2):46-53. PubMed ID: 17599367 [TBL] [Abstract][Full Text] [Related]
33. Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease. An C; Pu X; Xiao W; Zhang H Neurosci Lett; 2018 Feb; 665():236-239. PubMed ID: 29241707 [TBL] [Abstract][Full Text] [Related]
34. DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death. Saeed U; Ray A; Valli RK; Kumar AM; Ravindranath V Antioxid Redox Signal; 2010 Jul; 13(2):127-44. PubMed ID: 20014998 [TBL] [Abstract][Full Text] [Related]
35. Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Lev N; Ickowicz D; Melamed E; Offen D Neurotoxicology; 2008 May; 29(3):397-405. PubMed ID: 18377993 [TBL] [Abstract][Full Text] [Related]
36. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563 [TBL] [Abstract][Full Text] [Related]
37. Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models. Choi MS; Nakamura T; Cho SJ; Han X; Holland EA; Qu J; Petsko GA; Yates JR; Liddington RC; Lipton SA J Neurosci; 2014 Nov; 34(45):15123-31. PubMed ID: 25378175 [TBL] [Abstract][Full Text] [Related]
38. In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized. Terracciano C; Nogalska A; Engel WK; Wojcik S; Askanas V Free Radic Biol Med; 2008 Sep; 45(6):773-9. PubMed ID: 18601999 [TBL] [Abstract][Full Text] [Related]
39. Selective enrichment of DJ-1 protein in primate striatal neuronal processes: implications for Parkinson's disease. Olzmann JA; Bordelon JR; Muly EC; Rees HD; Levey AI; Li L; Chin LS J Comp Neurol; 2007 Jan; 500(3):585-99. PubMed ID: 17120294 [TBL] [Abstract][Full Text] [Related]
40. Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein. Bandopadhyay R; Miller DW; Kingsbury AE; Jowett TP; Kaleem MM; Pittman AM; de Silva R; Cookson MR; Lees AJ Neurosci Lett; 2005 Aug; 383(3):225-30. PubMed ID: 15955416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]